首頁 › 克隆氏症 › 加州 › Los Angeles
Los Angeles, CA 的 克隆氏症 臨床試驗
15 項針對 克隆氏症 的研究正在 Los Angeles（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
招募中3 期
- Cedars Sinai Medical Center ( Site 5080), Los Angeles
- UCLA Clinical & Translational Research Center (CTRC) ( Site 5116), Los Angeles
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
招募中3 期
- Cedars Sinai Medical Center, Los Angeles
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
招募中3 期
- TLC Clinical Research Inc, Los Angeles
- GastroIntestinal Bioscience, Los Angeles
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
招募中2/3 期
- TLC Clinical Research Inc, Los Angeles
- GastroIntestinal Bioscience, Los Angeles
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
招募中3 期
- TLC Clinical Research Inc.-Site Number: 8400030, Los Angeles
- GastroIntestinal Bioscience - Los Angeles-Site Number: 8400019, Los Angeles
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
招募中2 期
- Biopharma Informatic, LLC, Los Angeles
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
招募中2 期
- Biopharma Informatic, LLC, Los Angeles
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
招募中4 期
- Cedars-Sinai Medical Center, Los Angeles
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
招募中3 期
- Cedars Sinai Medical Center, Los Angeles
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
招募中
- Cedars-Sinai, Los Angeles
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
招募中3 期
- Keck Medicine Of USC - USC Healthcare Center 1, Los Angeles
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
招募中4 期
- Cedars-Sinai, Los Angeles
Precise Infliximab Exposure and Pharmacodynamic Control
招募中2/3 期
- Children's Hospital of Los Angeles, Los Angeles
Impact of Prebiotics in Ulcerative Colitis
招募中
- UCLA, Los Angeles
Stem Cell Transplantation in Crohn's Disease
招募中1/2 期
- Cedars-Sinai Medical Center, Los Angeles
其他城市的 克隆氏症 試驗
- New York City, NY35 項研究
- Boston, MA19 項研究
- Miami, FL19 項研究
- Cleveland, OH19 項研究
- St. Louis, MO19 項研究
- Tyler, TX17 項研究
- Orlando, FL17 項研究
- Houston, TX17 項研究
- Atlanta, GA17 項研究
- San Antonio, TX15 項研究
- San Diego, CA15 項研究
- Colorado Springs, CO13 項研究
Los Angeles 的其他研究
- 非小細胞肺癌87 項研究
- 癌症（所有類型）74 項研究
- 乳癌73 項研究
- 前列腺癌61 項研究
- 大腸直腸癌59 項研究
- 轉移性癌症57 項研究
- 卵巢癌50 項研究
- 肺癌45 項研究
- 頭頸部鱗狀細胞癌42 項研究
- 胰臟癌35 項研究
- 子宮內膜癌34 項研究
- 黑色素瘤34 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。